Morgan Stanley 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-06 4:24 pm Purchase | 2026-02-28 | 13G | X4 PHARMACEUTICALS INC XFOR | MORGAN STANLEY MS | 8,884,338 10.200% | 687,849 (+8.39%) | Filing |
| 2026-02-12 2:28 pm Purchase | 2025-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | MORGAN STANLEY MS | 8,196,489 9.400% | 8,196,489 (New Position) | Filing |